antiplatelet therapy [topp]
indication [idcn]
antiplatelet therapy [topp]
Prevention [topp]
Arterial thrombosis [dsyn]
Arterial [bpoc]
Thrombi [patf]
Platelets [cell]
Formed [ftcn]
condition [dsyn]
Elevated [qlco]
shear stress [npop]
Sites [spco]
atherosclerotic [ftcn]
Vascular injury [inpo]
Blood flow [orgf]
Aspirin [orch, phsu]
Antiplatelet agent [phsu]
Half [qnco]
century [phsu, vita]
Clinical Trials [resa]
Exposed [clna]
limitations [ftcn]
Aspirin [orch, phsu]
progress [ftcn]
effective [qlco]
Antiplatelet Agents [phsu]
New Agents [clas]
Based [ftcn]
interrupting [qlco]
Specific site [spco]
Sequence [nusq]
Platelet Activation [ortf]
inhibitors [chvf]
Initial [tmco]
Step [cnce]
Platelet adhesion [celf]
Experimental [qlco]
inhibitors [chvf]
Specific [qlco]
Platelet [cell]
Agonist [phsu]
Receptor Interactions [moft]
Antithrombins [aapp, bacs, phsu]
Thromboxane A>2< [eico]
receptor [aapp, rcpt]
antagonists [chvf]
Adenosine Receptor [aapp, rcpt]
diphosphate [inch, phsu]
Including [ftcn]
Ticlopidine [orch, phsu]
clopidogrel [orch, phsu]
inhibitors [chvf]
arachidonic acid metabolism [moft]
Thromboxane A>2< [eico]
Omega-3 Fatty Acids [bacs, lipd, phsu]
Aspirin [orch, phsu]
Non-steroidal anti-inflammatory drug [phsu]
arrested [dsyn]
Cyclo-Oxygenase [aapp, enzy]
Thromboxane synthase [aapp, enzy]
inhibitors [chvf]
Efficacy [qlco]
Agent [chvf]
Limited [ftcn]
actions [ftcn]
Restricted [ftcn]
Single [popg]
Specific [qlco]
Platelet [cell]
Receptors [aapp, rcpt]
Metabolic Pathways [ftcn]
Global [spco]
interruption [ftcn]
Final [tmco]
Step [cnce]
Platelet aggregation [celf]
Monoclonal Antibodies [aapp, imft]
RGD [aapp, bacs]
Arginine [aapp, bacs, phsu]
Glycine [aapp, bacs, phsu]
Aspartic Acid [aapp, bacs]
analogs [chvs]
Block [patf]
Ligand Binding [moft]
Platelet glycoprotein IIb-IIIa [aapp]
Complex [qlco]
Initial [tmco]
Clinical Trials [resa]
Novel [tmco]
Agent [chvf]
Superior [spco]
Efficacy [qlco]
PREVENT [phsu]
Reocclusion [inpo]
Restenosis [acab]
Following [tmco]
coronary angioplasty [topp]
Atherectomy [topp]
